Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Avraham Gabay

CFO at Oramed Pharmaceuticals Inc. (ORMP)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $421K

Reported trades

Filed Stock Type Shares Price Value Since
Oct 2SEC ORMPOramed Pharmaceuticals Inc. Sell Plan 20,000861,076 held (−2%) $4.51 $90K -9.8%
Jul 2SEC ORMPOramed Pharmaceuticals Inc. Sell Plan 73,360671,785 held (−10%) $4.51 $331K -9.8%
  • Sell

    CFO Avraham Gabay sold $90K of ORMP at $4.51 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Avraham Gabay sold $331K of ORMP at $4.51 — pre-scheduled 10b5-1 plan sale.